Tag:
Zavesca
Latest Headlines
Latest Headlines
FDA panel backs Actelion's Zavesca
An expert FDA panel has voted 10-3 to support Actelion's Zavesca for a rare illness called Niemann-Pick type C disease. Those who voted in favor of the drug maintain that even though Zavesca did not
ALSO NOTED: Avastin approval may lower FDA bar; GTX shares skyrocket on cancer data; Novartis wins approval; and much more...
> Medicure shares plunged 80 percent this morning after the developer announced that its lead therapy, MC-1 for cardiovascular disease, failed to meet its primary endpoint in a late-stage trial.
